
The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers
DEA Registrants could be the real winner if cannabis is rescheduled
DEA Registrants could be the real winner if cannabis is rescheduled
It’s been a wild week in the rulemaking around marijuana rescheduling, to say the least. I’ve started writing about it a couple of times, only to be whipsawed by filings, rulings, prominent hot takes, prominent rebuttals, and more. All while trying to do my real job here at the firm. Below are my thoughts on
Cannabis concentrates have become a cornerstone of modern cannabis consumption, offering a potent, clean, and diverse way to experience cannabinoids and terpenes. These products, ranging from shatter to wax and live resin, are derived through sophisticated extraction methods that deliver enhanced flavors and intensities for consumers. For both seasoned cannabis users and industry professionals, understanding
On Thursday, November 7th, Vince Sliwoski and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay! Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar: Panelists: Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial
Last Thursday, we learned that the DEA’s marijuana rescheduling hearings are delayed until early next year. We also saw the list of 25 participants invited by the DEA to testify at those hearings. The takeaways here are: a) we will not have a substantive hearing on marijuana rescheduling until a new President takes office, and
Election Day is next Tuesday, November 5. I have plenty of thoughts! Today I’ll stay in my lane, though, and focus on the cannabis state ballot measures. The voting states this time around include Florida, Nebraska, North Dakota and South Dakota. I’m aware of one other jurisdiction is doing work around the edges– namely, Oregon’s
In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice of proposed rulemaking (NPRM) to move both marijuana and marijuana extract from schedule I to schedule III of the federal Controlled Substances Act (CSA). The comment submission deadline is
Arizona’s record-breaking cannabis market In the landscape of booming and busting cannabis markets, Arizona emerges as a standout success story. A naturally beautiful state that attracts a sizeable group of tourists every year, Arizona skyrocketed past $1 billion in total cannabis sales for 2023. Unlike its northern neighbor of Nevada, Arizona has exceeded $1 billion
In November 2012, Washington voters approved the production, processing, and retail sales of recreational cannabis within Washington state under what is known as Initiative 502 (“I-502”). Washington state then provided a regulatory framework for how the legalization of recreational cannabis production, processing, and retail sales would be regulated under what would become the Washington State
Mississippi’s Initiative 65 Easily one of the biggest legislative surprises of the 2020 was the passing of Mississippi’s Initiative 65, a medical cannabis bill with an extensive qualifying conditions list. In arguably the reddest and most socially conservative state in America — where only one Democrat has served as Governor since 1992, and where Republicans
Notifications